Skip to main content
. 2015 Jan 27;10:609–631. doi: 10.2147/IJN.S71198

Figure 6.

Figure 6

Comparison of anti-inflammatory efficacy of PLGA-PEG NPs, PLGA-PEG-peptide NPs, and Ocufen® in the (A) treatment and (B) prevention of ocular inflammation induced by SA in the rabbit eye.

Notes: Values are expressed as mean ± SD; *P<0.05, **P<0.01, and ***P<0.001 significantly lower than the inflammatory effect induced by SA; $P<0.05, $$P<0.01, and $$$P<0.001 significantly lower than anti-inflammatory efficacy of Ocufen®.

Abbreviations: HIV-Tat, human immunodeficiency virus transactivator; NPs, nanoparticles; PEG, polyethyleneglycol; PLGA, poly(lactic-co-glycolic acid); POD, peptide for ocular delivery; SA, sodium arachidonate; SD, standard deviation.